(Stroke. 2001;32:636.)
© 2001 American Heart Association, Inc.
Original Contributions |
From the Institute of Laboratory Animal Science (T.M., T.T., J.T.) and the Department of Neurosurgery (T.M., T.A.), Saitama Medical Center/School, Saitama, and the Department of Neurosurgery (K.N.), Showa General Hospital, Tokyo, Japan.
Correspondence to Takao Asano, MD, Department of Neurosurgery, Saitama Medical Center/School, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan. E-mail asano{at}ns2.saitama-med.ac.jp
| Abstract |
|---|
|
|
|---|
MethodsSAH or sham operation was induced according to a 2-hemorrhage model in a total of 24 beagle dogs. On day 2 or 7 after SAH or sham operation, dogs were intrathecally infused with buffer containing Mn2+ and DAB, and the brain stem was prepared for light and electron microscopy. Possible colocalization of ferrous (Fe2+) or ferric (Fe3+) iron ions with ·O2- was also examined with the use of Turnbull blue or Berlin blue staining, respectively.
ResultsLight microscopy revealed amorphous, amber deposits within the subarachnoid hematoma, the periarterial space, and the tunica adventitia of the basilar artery on days 2 and 7 after SAH. ·O2- deposits were eliminated by addition of superoxide dismutase or exclusion of either Mn2+ or DAB from the perfusate, confirming the specificity of the reaction. These deposits were colocalized with blue reaction deposits indicating Fe2+ and Fe3+. Within the subarachnoid space, ·O2- indicating electron-dense fine granules were preferentially located around degenerated erythrocytes and, secondarily, infiltrating macrophages and neutrophils.
ConclusionsWe show direct evidence for enhanced production of ·O2- and Fe2+/Fe3+ iron ions in the subarachnoid space after SAH, lending further support to the pathogenic role of ROS in cerebral vasospasm after SAH.
Key Words: reactive oxygen species subarachnoid hemorrhage superoxides vasospasm, intracranial dogs
| Introduction |
|---|
|
|
|---|
Evidence for ROS production in vivo after SAH has been assessed by indirect approaches such as measurement of lipid peroxide production and quantification of superoxide dismutase (SOD) and glutathione peroxidase activities.18 Although more direct approaches have been used for the detection of ROS in brain tissue, such as nitroblue tetrazolium,19 electron spin resonance,20 fluorochemical sensor,21 and histochemical methods,22 direct detection in situ of ROS, including ·O2-, has not yet been performed for cerebral vasospasm after SAH.
In this study we used a modification of Karnovskys manganese/diaminobenzidine (Mn2+/DAB) technique that we have previously reported.22 This method yields an amber osmiophilic polymer that is formed in the presence of ·O2-, Mn2+, and DAB and can be visualized under both light and electron microscopes.23 Using this technique, we sought to elucidate in this study the major sites and cellular species responsible for ·O2- production in the subarachnoid space after SAH. As the Haber-Weiss and Fenton reactions require iron ions as cofactors to yield other species of ROS, we also investigated whether Fe2+ or Fe3+ iron ions coexisted with ·O2-, using Turnbull blue or Berlin blue staining, respectively.
| Materials and Methods |
|---|
|
|
|---|
Surgical Procedures
Animal housing and care and the present protocols
complied with the Principles of Laboratory
Animal Care and the Guide for
the Care and Use of Laboratory Animals (Department of Health
and Human Services publication No. [NIH] 85-23, revised 1985) and
have previously been approved by the Animal Use Ethical Committee of
the Saitama Medical School.
Subarachnoid Hemorrhage
Model
Twenty-four adult beagle dogs of either sex, weighing
10 to 15 kg, were randomly assigned to treatment groups. Animals were
anesthetized with injection of sodium pentobarbital (30 mg/kg
IV), orally intubated, and fixed in a stereotaxic device.
Animals were maintained by mechanical ventilation with room air
throughout the experiment. To rule out fluctuation of diameter of the
cerebral artery due to variation in
PCO2,
arterial blood gas levels were maintained within
physiological ranges during the course of the
procedure. Additionally, rectal temperature was kept within the normal
range with the use of a feedback-regulated heating pad. With an aseptic
technique, the right vertebral artery was cannulated with a
polyethylene catheter (0.86 mm), through which vertebral
angiography (baseline angiogram) was performed with the use of 8 mL
meglumine diatrizoate at a rate of approximately 3 mL/s by manual
injection. SAH (first induction=day 0) was produced according to the
2-hemorrhage canine model of
SAH.24 Briefly, 0.6 mL/kg
body wt of autologous, nonheparinized fresh arterial blood
was injected percutaneously into the cisterna magna
over 1 minute, followed by removal of one half of that volume of
cerebrospinal fluid. Animals were maintained in the prone position with
the neck flexed 30° down for 30 minutes to allow the injected blood
to accumulate in the prepontine cistern. All animals were treated with
antibiotics and other postoperative care, including regular wound
cleaning, during the course of the experiment. The cisternal injection
of arterial blood was repeated 48 hours later by the same
method. Additional angiography was performed to confirm the narrowing
of the basilar artery on day 2 or 7. In the animals subjected to sham
treatment, an identical amount of physiological
saline was injected into the cisterna magna, and angiography was
performed on days 2 and 7 according to the method described
below.
Evaluation of the Basilar Artery
Diameter
The diameter of the basilar artery was measured at 5
predetermined locations along the vessel on the angiogram with an
optical micrometer. Examination of all films was performed
in a blind fashion by a single investigator. Arterial
narrowing on the angiogram was expressed as a percentage of the basilar
artery diameter of the baseline angiogram obtained on day 0 in the same
animals, and the accumulated angiography data in SAH and sham groups
were expressed as mean±SE. For statistical comparisons, ANOVA was
used. A P value of <0.05 was
considered statistically significant.
Intrathecal Perfusion
Procedure
After angiography on day 2 or 7, a 4-cm-long midline
skin incision starting from the external occipital protuberance was
made under general anesthesia. The nuchal muscles were
divided in the midline, exposing the atlanto-occipital membrane.
Through a small incision made in the membrane, 2 silicon catheters
(1.2 mm in diameter, 10 cm long) were separately inserted into
either side of the cerebellomedullary cisterns. One was connected to
the perfusion tube, while the other was connected to the draining tube.
The length of the catheters in the subarachnoid space was
approximately 1.5 cm, which was sufficient to reach the prepontine
cistern. The opening of the atlanto-occipital membrane was closed in a
watertight fashion by the use of a surgical adhesive material. Then the
basal cistern was perfused for 10 minutes with 10 mL
Mn2+/DAB buffer on day 2 (group 1; n=6) or 7
(group 2; n=6). Separate groups of animals were similarly perfused on
day 7 with Mn2+/DAB buffer containing hrSOD
(group 3; n=3), non-Mn2+ (group 4; n=3), or
non-DAB buffer (group 5; n=3). Animals subjected to sham treatment were
perfused with Mn2+/DAB buffer on day 7
(group 6; n=3). The preliminary study, in which 3 dogs were subjected
to perfusion using identical amounts of dye (4% toluidine
bluesaline) solution, had shown that the basal as well as the
prepontine cisterns were satisfactorily perfused by the above
technique.
Pathological Studies
After intrathecal perfusion with the
designated perfusate, animals were euthanatized by an injection
of sodium pentobarbital (50 mg/kg IV) followed by exsanguination. The
basilar artery together with the brain stem was immediately harvested
and processed for light and electron microscopy. Sections for light
microscopy were immersed in a phosphate buffer containing 4%
paraformaldehyde, routinely embedded in paraffin,
sectioned (3 µm), counterstained with 4% methyl green, and mounted.
Additionally, to examine the coexistence of
Fe2+ or Fe3+ iron
ions together with
·O2-, either
Turnbull blue or Berlin blue staining was done according to standard
protocols. Sections for electron microscopy were trimmed into small
pieces (approximately 1x1x2 mm), fixed in 2.5%
glutaraldehyde followed by 1% osmium tetroxide
fixation, dehydrated through a graded series of ethanol solutions,
transferred to propylene oxide, and embedded in Quetol 812. Serial
semithin sections (1 µm) from resin-embedded blocks were then stained
with 1% safranine/0.5% toluidine blue. Ultrathin sections (70 nm)
were double-stained with uranium acetate and lead citrate and were
examined at 75 kV with a Hitachi H-7000 transmission electron
microscope.
Evaluation of
·O2- and
Fe2+/Fe3+
Reaction Products
Using light microscopy, amounts of
·O2- and
Fe2+/Fe3+
reaction products were graded in a semiquantitative fashion as
absent (-), slight (±), mild (+), or moderate (++) in the
subarachnoid space as well as the basilar arterial
wall in a blinded fashion. Sections graded as absent or slight were
further examined by electron microscopy. Statistical analysis
was performed by the Kruskal-Wallis test followed by post hoc
comparison by the Mann-Whitney
U test. A
P value of <0.05 was
considered statistically
significant.
| Results |
|---|
|
|
|---|
In animals subjected to sham treatment, there was no significant time-dependent change in the basilar artery diameter (99.3±2.4% [mean±SE] on day 2 and 98.5±2.1% on day 7; n=3 for group 6; P>0.05). A statistically significant difference in the basilar artery diameter was revealed between the SAH groups and the sham treatment group (P<0.01 for each comparison) on either day 2 or 7. In animals subjected to SAH, the basilar artery diameter was reduced to 72.1±2.8% of the control on day 2 (data assembled from groups 1 to 5; n=21). The reduction in basilar artery diameter on day 7 (58.6±3.2%, data assembled from groups 2 to 5; n=15) was significantly greater than that on day 2 (P<0.05).
Histochemical Distributions of
Reaction Products of
·O2-,
Fe2+, and
Fe3+
Dotlike or speckled amber reaction deposits were
visible even by surgical microscopy in groups 1 and 2
(Mn2+/DAB buffer) at the time of death on
days 2 and 7 after SAH. Interestingly, small amounts of dotlike amber
reaction products were observed on the dorsal and ventral surfaces
of the brain stem in group 6 (sham treatment). Reaction deposits were
not observed in groups 3 (Mn2+/DAB buffer
containing hrSOD), 4 (non-Mn2+), or 5
(non-DAB).
As summarized in the
Table
,
light microscopic observation revealed
·O2- and
Fe2+/Fe3+ iron
ion deposits in the subarachnoid space and the basilar
arterial wall in animals subjected to SAH. In groups 1 and
2, mild to moderate amounts of amorphous amber reaction deposits were
observed surrounding degenerated erythrocytes and, less so, around
infiltrating macrophages and neutrophils in the
subarachnoid space on days 2 and 7. Within the basilar
arterial wall, slight to mild amounts of reaction deposits
were observed exclusively in the tunica adventitia. Although the
localization of
·O2- reaction
deposits was similar between days 2 and 7, their amount appeared to
increase (but was not statistically significant) on day 7 after SAH. In
group 6 (sham treatment) on day 7, small amounts of amorphous amber
reaction deposits were observed in the subarachnoid space,
abutting the arachnoid membrane and the pia mater. In groups 3
(perfused with Mn2+/DAB buffer containing
hrSOD), 4 (non-Mn2+), and 5 (non-DAB), no
reaction deposits of
·O2- were
observed in either the subarachnoid space or the basilar
arterial wall
(Figure 1
). In groups 1 to 5, Turnbull blue or Berlin blue
staining revealed the presence of a significant amount of amorphous
blue reaction deposits, indicating the presence of
Fe2+ or Fe3+ iron
ions, around the basilar artery and degenerated erythrocytes in the
subarachnoid space. It is important to note that these blue
reaction deposits were found in the close vicinity of
·O2- reaction
deposits. Considerable amounts of reaction deposits were also observed
within the tunica adventitia of the basilar arterial wall
(Figure 2
). While the aforementioned pattern of
colocalization of
·O2- reaction
deposits and Fe2+ or
Fe3+ reaction deposits within the
subarachnoid space and the basilar arterial wall
was similar between days 2 and 7, the amount of those deposits was
slightly, but not significantly, increased on day 7. In group 6, no
Fe2+ or Fe3+
reaction products were observed in either the subarachnoid
space or the basilar arterial wall.
|
|
|
Electron microscopic examination in groups 1 and 2 revealed
that electron-dense fine granules of varying size indicating
·O2- were
abundantly present in the subarachnoid space, predominately
located around degenerated erythrocytes and, much more secondarily, in
the vicinity of infiltrating macrophages and neutrophils.
Considerable numbers of granules were attached to the outer surface of
the cytoplasmic membrane of those cells. In the basilar
arterial wall,
·O2- reaction
deposits were also detected in the vicinity of infiltrating
macrophages and neutrophils in the tunica adventitia of the
basilar artery
(Figure 3
.). In group 6 on day 7, small amounts of
·O2- reaction
products were present in the subarachnoid space
juxtaposed to the arachnoid membrane and the pia mater. No
·O2- reaction
deposits were identified by electron microscopy in group 3, 4, or 5 in
either the subarachnoid space or the basilar
arterial wall.
|
In the basilar arterial wall of groups 1 to 5, mild to moderate pathological changes were observed in endothelial and smooth muscle cells on days 2 and 7. These changes include increased number of a variety of cytoplasmic organelles (mitochondria, lysosomes, and rough endoplasmic reticulum), cytoplasmic vacuoles containing fine granules, myelin figures or more amorphous material, and detached intracellular junctions. These pathological findings appeared more conspicuous with time. Furthermore, in groups 1 and 2, although moderate vacuole formation and destruction of collagen fibers in the tunica adventitia close to the deposits was observed, there were no necrotic cell changes in the tunica media and intima. In addition, small numbers of activated macrophages were observed in the tunica adventitia. In group 6, no abnormal findings were observed in any of the specimens.
| Discussion |
|---|
|
|
|---|
By the use of the aforementioned technique, we were able to confirm that SAH leads to generation of ·O2- as follows. Light and electron microscopy revealed that ·O2- reaction deposits were primarily located around erythrocytes. However, a significant amount of deposits was also observed around infiltrating macrophages and neutrophils in the extracellular space of the subarachnoid hematoma, the periarterial space, and the tunica adventitia of the basilar artery on days 2 and 7 after SAH. Furthermore, Turnbull blue and Berlin blue staining revealed that these ·O2- reaction deposits were tightly colocalized with Fe2+ or Fe3+ reaction deposits, providing evidence that Haber-Weiss and Fenton reactions are taking place in the subarachnoid space after SAH.
Confirmation of
·O2- Reaction
Deposits
The rationale of the histochemical technique for the
detection of ·O2-
production is as
follows25 26 :
![]() | (1) |
![]() |
![]() | (2) |
Reactions 1 and 2 are competitive; however, the rate constant (K2) of reaction 2 is 3 orders of magnitude greater than the rate constant (K1) of reaction 1. Thus, if reaction 1 is halted by the addition of a nonlimiting amount of SOD (experimental group 3), reaction deposits formed in the absence of SOD (experimental groups 1 and 2) could be interpreted as specific evidence of ·O2- production. Such a confirmatory strategy revealed that, in dogs subjected to SAH, ·O2- reaction deposits were completely diminished when an excess amount of hrSOD was added to the Mn2+/DAB buffer (experimental group 3). As additional controls to determine the specificity of the reaction deposits produced by the complete reaction buffer, we eliminated DAB or Mn2+ from the perfusion buffer (experimental groups 4 and 5). As expected, no reaction deposits were present in these conditions. Additionally, sodium azide (1 mmol/L, a concentration at which the enzymatic activities of CuZn SOD or Mn SOD are not inhibited27 ) was added to all perfusates to block the nonspecific osmiophilic polymerization between DAB and endogenous peroxidase, catalase, and mitochondrial cytochrome oxidase enzymes.23 Furthermore, to examine the possibility of nonspecific polymerization of DAB by endogenous H2O2, we added 3% H2O2 to the Mn2+/DAB buffer. The addition of H2O2 did not elicit the formation of amber reaction deposits. Taken together, our results indicate that the reaction deposits observed in experimental groups 1 and 2 are specifically due to enhanced production of ·O2-. Noteworthy is the finding that small numbers of ·O2- reaction deposits were observed in the subarachnoid space abutting the arachnoid and pia mater in sham-treated animals subjected to perfusion with the Mn2+/DAB buffer (experimental group 6). The aforementioned result may be consonant with the basic, physiological production of ·O2- in the subarachnoid space, which may have been enhanced as a response to sham operation.
Possible Origin of
·O2- and
Fe2+/Fe3+ Iron
Ions
Although oxyHb liberated into the subarachnoid
space through clot lysis has been deemed to be the primary source of
ROS and iron ions, this thesis has suffered from a lack of direct
evidence. In this regard, the present study provides histochemical
evidence for enhanced production of
·O2- and its
coexistence with Fe2+ or
Fe3+ iron ions in the subarachnoid
space on days 2 and 7 after SAH. While
·O2- reaction
deposits were detected within the subarachnoid hematoma, the
periarterial space, and the tunica adventitia of the
basilar artery, they were particularly abundant around degenerated
erythrocytes and, secondarily, infiltrating macrophages and
neutrophils. However, we did not detect deposits in the tunica media or
intima. In this regard, it is important to note whether the
Mn2+/DAB perfusate used can freely
penetrate into the smooth muscle and endothelial cell
layers. As DAB is poorly able to cross the blood-brain barrier and
arterial wall, it is likely that this lack of detection may
be related to limited distribution of
Mn2+/DAB perfusate when applied to
the subarachnoid space. Additionally, as the life of
·O2- is
considerably short, it remains possible that this species had already
decayed in these regions before detection. Therefore, we cannot
assuredly exclude the possibility that
·O2- is produced
in the media and endothelial cells of the vascular wall
after SAH.
Regarding the cellular source(s) of ·O2-, they were particularly abundant around degenerated erythrocytes and, less so, near infiltrating macrophages and neutrophils. The aforementioned result indicates that ·O2- is derived not only from autoxidation of oxyHb but also from infiltrating activated macrophages and neutrophils. In this regard, it is interesting to note that intrathecal injection of talc (crystallized hydrous magnesium silicate) in dogs induces severe foreign body (nonspecific inflammatory) reaction in the subarachnoid space accompanied by significant arterial narrowing and structural damage, thereby mimicking in many ways cerebral vasospasm after SAH, but without evidence of extravasated erythrocytes. These arterial changes were significantly attenuated by intrathecal administration of SOD, suggesting that foreign body reaction mediated via infiltrating macrophages and neutrophils may contribute to cerebral vasospasm.3 Nonetheless, data presented herein support the hypothesis that ·O2- as a result of autoxidation of extravasated erythrocyte-derived Hb is the primary contributor to the pathogenesis of cerebral vasospasm after SAH.
Finally, it seems likely that the main source of Fe2+ or Fe3+ iron products in this study is lysate from subarachnoid blood clots, although an alternate possibility is that some Fe2+ or Fe3+ iron ions were released from degenerating infiltrating macrophages during erythrophagocytosis, which is known to occur in SAH.
Possible Pathogenetic Role of Intracisternally Generated
·O2- and
Fe2+/Fe3+ Iron
Ions
Mounting evidence suggests that oxyHb has a wide spectrum of biological actions that include the following: (1) generation of ROS, (2) a direct vasoconstrictive effect ex vivo, and (3) scavenging of NO. The chemical pathway whereby oxyHb leads to the ROS cascade together with Fe2+ or Fe3+ iron ions is based on the Haber-Weiss and Fenton reactions. The importance of the present study lies in the fact that it demonstrated the coexistence of ·O2- with Fe2+ or Fe3+ iron ions. Such an environment certainly favors the occurrence of Haber-Weiss or Fenton reactions, leading to generation of the most harmful species of ROS, ie, ·OH.5 6 Furthermore, peroxynitrite generation as a consequence of the direct interaction between NO and ·O2- may also be an important ROS contributor to the pathogenesis of SAH, as its formation is approximately 3.5 times faster than its dismutation by SOD.28 29 Collectively, ROS initiate oxidative damage of DNA, mitochondria, and, most importantly, membrane phospholipids. Lipid peroxidation, in turn, brings about the activation of membrane phospholipase A2, release of arachidonic acid, intercellular accumulation of diacylglycerol, and activation of protein kinase C.30 31 32 Although the generation of ·O2- in the present study was detected only in the adventitia of the vascular wall and subarachnoid space due to technical limitations, markedly increased levels of ·O2- may cause an imbalance of endothelial vasoactivity (induction of vasoconstriction when the ratio of ·O2- to NO is increased)9 as well as upregulation of adhesion molecules (such as intercellular adhesion molecule-1 [ICAM-1] and vascular cell adhesion molecule-1 [VCAM-1]),33 leading to microcirculatory derangement. To conclude that ROS are primary in the pathogenesis of cerebral vasospasm after SAH, however, further experiments are warranted to detect ROS, including ·O2-, in the arterial wall. Nonetheless, the present study is the first step toward direct evidence of ROS in the pathogenesis of cerebral vasospasm after SAH.
Thus, on the basis of the aforementioned ROS cascade-promoting reactions, a variety of antioxidants such as SOD,9 the ·OH scavenger AVS [(+/-)-N, N'-propylenedinicotinamide],11 13 ebselen (an agent exhibiting glutathione peroxidaselike activity),12 14 the antioxidant aminosteroid,7 8 the singlet oxygen scavenger histidine,10 and iron chelators15 16 17 have been shown to be prophylactic against cerebral vasospasm in animal models as well as in SAH patients. Of particular interest is the Fe2+ chelator 2,2'-dipyridyl, which has been shown to completely prevent delayed vasospasm in a primate model of SAH,17 pointing to an important role of the Fe2+ iron ion in the pathogenesis of cerebral vasospasm, as ROS formation requires the ferrous moiety and Fe2+ is a potent trapping agent for NO. In this regard, the histochemical evidence presented in this report may provide one mechanism to explain why the Fe2+ chelator 2,2'-dipyridyl appears to prevent delayed vasospasm after SAH.
In conclusion, the present study provides histochemical evidence for enhanced production of ·O2- and Fe2+/Fe3+ iron ions in the subarachnoid clot as well as in the adventitia of the arterial wall on days 2 and 7 after SAH. Thus, ·O2- itself and subsequently generated ROS, particularly ·OH, are considered to play a primary role in the pathogenesis of cerebral vasospasm after SAH.
| Acknowledgments |
|---|
Received September 29, 2000; revision received November 27, 2000; accepted December 11, 2000.
| References |
|---|
|
|
|---|
2. Asano T, Sasaki T, Koide T, Takakura K, Sano K. Experimental evaluation of the beneficial effect of an antioxidant on cerebral vasospasm: the effect of an antioxidant on cerebral vasospasm. Neurol Res. 1984;6:4953.[Medline] [Order article via Infotrieve]
3. Mori T, Nagata K, Ishida T, Ohami H, Asano T. Superoxide anions in the pathogenesis of talc-induced cerebral vasocontraction. Neuropathol Appl Neurobiol. 1995;21:378385.[Medline] [Order article via Infotrieve]
4.
MacDonald RL, Weir
BKA. A review of hemoglobin and the pathogenesis of chronic cerebral
vasospasm. Stroke. 1991;22:971982.
5.
Haber F, Weiss J.
The catalytic decomposition of hydrogen peroxidase by iron salts.
Proc R Soc Lond A. 1934;147:332351.
6. Fenton HJH. Oxidation of tartaric acid in the presence of ion. J Chem Soc. 1894;23:899910.
7. Vollmer DG, Kassel NF, Hongo K, Ogawa H, Takahara T. Effect of the non-glucocorticoid U74006F in experimental cerebral vasospasm. Surg Neurol. 1989;31:190194.[Medline] [Order article via Infotrieve]
8. Toru M, Asano T. Effect of new 21-aminosteroid tirilazad mesylate (U74006F) on chronic cerebral vasospasm in a "two-hemorrhage" model of beagle dogs. Neurosurgery. 1994;34:10351039.[Medline] [Order article via Infotrieve]
9. Shishido T, Suzuki R, Qian L, Qian L, Hirakawa K. The role of superoxide anions in the pathogenesis of cerebral vasospasm. Stroke. 1994;25:864868.[Abstract]
10. Fadel MM, Foley PL, Kassell NF, Lee KS. Histidine attenuates cerebral vasospasm in a rabbit model of subarachnoid hemorrhage. Surg Neurol. 1995;43:5258.[Medline] [Order article via Infotrieve]
11. Asano T, Takakura K, Sano K, Kikuchi H, Nagai H, Tamura A, Ochiai C, Sasaki T. Effect of a hydroxyl radical scavenger on delayed ischemic neurological deficits following aneurysmal subarachnoid hemorrhage: results of a multicenter, placebo-controlled double-blind trial. J Neurosurg. 1996;84:792803.[Medline] [Order article via Infotrieve]
12. Watanabe T, Nishiyama M, Hori T, Asano T, Shimizu T, Masayasu H. Ebselen ameliorates delayed cerebral vasospasm in a canine two-hemorrhage model. Neurol Res. 1997;19:563565.[Medline] [Order article via Infotrieve]
13. Germano A, Imperatore C, dAvella D, Costa G, Tomasello F. Antivasospastic and brain-protective effects of a hydroxyl radical scavenger (AVS) after experimental subarachnoid hemorrhage. J Neurosurg. 1998;88:10751081.[Medline] [Order article via Infotrieve]
14. Saito I, Asano T, Sano K, Takakura K, Abe H, Yoshimoto T, Kikuchi H, Ohta T. Neuroprotective effect of an antioxidant, ebselen, in patients with delayed neurological deficits after aneurysmal subarachnoid hemorrhage. Neurosurgery. 1998;42:269277.[Medline] [Order article via Infotrieve]
15. Vollmer DG, Hongo K, Ogawa H, Tsukahara T, Kassell NF. A study of the effectiveness of the iron-chelating agent deferoxamine as vasospasm prophylaxis in a rabbit model of subarachnoid hemorrhage. Neurosurgery. 1991;28:2732.[Medline] [Order article via Infotrieve]
16. Arthur AS, Fergus AH, Lanzino G, Mathys J, Kassell NF, Lee KS. Systemic administration of the iron chelator deferiprone attenuates subarachnoid hemorrhage-induced cerebral vasospasm in the rabbit. Neurosurgery. 1997;41:13851391.[Medline] [Order article via Infotrieve]
17. Horky LL, Pluta RM, Boock RJ, Oldfield EH. Role of ferrous iron chelator 2,2'-dipyridyl in preventing delayed vasospasm in a primate model of subarachnoid hemorrhage. J Neurosurg. 1998;88:298303.[Medline] [Order article via Infotrieve]
18. Sakaki S, Ohta S, Nakamura H, Takeda S. Free radical reaction and biological defense mechanism in the pathogenesis of prolonged vasospasm in experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab. 1988;8:18.[Medline] [Order article via Infotrieve]
19.
Wei EP, Kontos
HA, Christman CW, Dewitt DS, Povishock JT. Superoxide generation and
reversal of acetylcholine-induced cerebral arteriolar dilation after
acute hypertension. Circ Res. 1985;57:781787.
20. Tominaga T, Imaizumi S, Yoshimoto T, Suzuki J, Fujita Y. Application of spin-trapping study to rat ischemic brain homogenate incubated with NADPH and Fe-EDTA. Brain Res. 1987;402:370372.[Medline] [Order article via Infotrieve]
21.
Murakami K, Kondo
T, Kawase M, Li Y, Sato S, Chen SF, Chan PH. Mitochondrial
susceptibility to oxidative stress exacerbates cerebral infarction that
follows permanent focal cerebral ischemia in mutant mice with
manganese superoxide dismutase deficiency.
J Neurosci. 1998;18:205213.
22. Mori T, Asano T, Matsui T, Muramatsu H, Ueda M, Kamiya T, Katayama Y, Abe T. Intraluminal increase of superoxide anion following transient focal cerebral ischemia in rats. Brain Res. 1999;816:350357.[Medline] [Order article via Infotrieve]
23. Briggs RT, Robinson JM, Karnovsky ML, Karnovsky MJ. Superoxide production by polymorphonuclear leukocytes: a cytochemical approach. Histochemistry. 1986;84:371378.[Medline] [Order article via Infotrieve]
24. Varsos VG, Liszczak TM, Han DH, Kistler JP, Vielma J, Black PM, Heros RC, Zervas NT. Delayed cerebral vasospasm is not reversible by aminophylline, nifedipine, or papaverine in a "two-hemorrhage" canine model. J Neurosurg. 1983;58:1117.[Medline] [Order article via Infotrieve]
25. Kono Y, Takahashi M, Asada K. Oxidation of manganous pyrophosphate by superoxide radicals and illuminated spinach chloroplasts. Arch Biochem Biophys. 1976;174:454462.[Medline] [Order article via Infotrieve]
26. Fridovich I. Superoxide dismutases. Annu Rev Biochem. 1975;44:147159.[Medline] [Order article via Infotrieve]
27. Misra HP, Fridovich I. Inhibition of superoxide dismutase by azide. Arch Biochem Biophys. 1978;189:317322.[Medline] [Order article via Infotrieve]
28.
Beckman JS,
Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical
production by peroxynitrate: implications for
endothelial injury from nitric oxide and superoxide.
Proc Natl Acad Sci
U S A. 1990;87:16201624.
29. Freeman BA, White CR, Gutierrez H, Paler-Martinez A, Tarpey MM, Rubbo H. Oxygen radical-nitric oxide reactions in vascular diseases. Adv Pharmacol. 1995;34:4569.
30. Tyler DD. Role of superoxide radicals in the lipid peroxidation of intracellular membranes. FEBS Lett. 1975;51:180183.[Medline] [Order article via Infotrieve]
31. Matsui T, Takuwa Y, Johshita H, Yamashita K, Asano T. Possible role of protein kinase C-dependent smooth muscle contraction in the pathogenesis of chronic cerebral vasospasm. J Cereb Blood Flow Metab. 1991;11:143149.[Medline] [Order article via Infotrieve]
32. Takuwa Y, Matsui T, Abe Y, Nagafuji T, Yamashita K, Asano T. Alterations in protein kinase C activity and membrane lipid metabolism in cerebral vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 1993;13:409415.[Medline] [Order article via Infotrieve]
33. Fraticelli A, Serrano CV Jr, Bochner BS, Capogrossi MC, Zweier JL. Hydrogen peroxide and superoxide modulate leukocyte adhesion molecule expression and leukocyte endothelial adhesion. Biochim Biophys Acta. 1996;1310:251259. [Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
G. S. Kim, J. E. Jung, K. Niizuma, and P. H. Chan CK2 Is a Novel Negative Regulator of NADPH Oxidase and a Neuroprotectant in Mice after Cerebral Ischemia J. Neurosci., November 25, 2009; 29(47): 14779 - 14789. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Zemke, M. U Farooq, A. Mohammed Yahia, and A. Majid Delayed ischemia after subarachnoid hemorrhage: result of vasospasm alone or a broader vasculopathy? Vascular Medicine, August 1, 2007; 12(3): 243 - 249. [Abstract] [PDF] |
||||
![]() |
M. Yamaguchi, C. Zhou, D. D. Heistad, Y. Watanabe, and J. H. Zhang Gene Transfer of Extracellular Superoxide Dismutase Failed to Prevent Cerebral Vasospasm After Experimental Subarachnoid Hemorrhage Stroke, November 1, 2004; 35(11): 2512 - 2517. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Suzuki, M. Muramatsu, T. Kojima, and W. Taki Intracranial Heme Metabolism and Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage Stroke, December 1, 2003; 34(12): 2796 - 2800. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Faraci Vascular Protection Stroke, February 1, 2003; 34(2): 327 - 329. [Full Text] [PDF] |
||||
![]() |
Y. Watanabe, Y. Chu, J. J. Andresen, H. Nakane, F. M. Faraci, and D. D. Heistad Gene Transfer of Extracellular Superoxide Dismutase Reduces Cerebral Vasospasm After Subarachnoid Hemorrhage Stroke, February 1, 2003; 34(2): 434 - 440. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. McGirt, A. Parra, H. Sheng, Y. Higuchi, T. D. Oury, D. T. Laskowitz, R. D. Pearlstein, and D. S. Warner Attenuation of Cerebral Vasospasm After Subarachnoid Hemorrhage in Mice Overexpressing Extracellular Superoxide Dismutase Stroke, September 1, 2002; 33(9): 2317 - 2323. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Didion, C. A. Hathaway, and F. M. Faraci Superoxide levels and function of cerebral blood vessels after inhibition of CuZn-SOD Am J Physiol Heart Circ Physiol, October 1, 2001; 281(4): H1697 - H1703. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Saito, H. Kamii, I. Kato, S. Takasawa, T. Kondo, P. H. Chan, H. Okamoto, T. Yoshimoto, and R. L. Macdonald Transgenic CuZn-Superoxide Dismutase Inhibits NO Synthase Induction in Experimental Subarachnoid Hemorrhage Editorial Comment Stroke, July 1, 2001; 32(7): 1652 - 1657. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |